While a rich T cell (CD3+) infiltrate correlates, per se, positively with a longer survival in several cancers, concurrent enrichment in CD8+ plus CD4+ T cells seems to be required for a better prognosis in some cancers, including head and neck squamous cell carcinomas (HNSCCs) [89]. Here, CD4 is linked to cancer.